University of Iowa Hospitals and Clinics
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Participants in this study have been diagnosed with adenocarcinoma of the pancreas, a type of pancreatic cancer. The purpose of this study is to see if using pharmacological ascorbate and gemcitabine chemoradiation is safe and effective in treating pancreatic cancer. Approximately 30 people will take part in this study at the University of Iowa.
Sandy Vollstedt 319-356-4422
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.